"the drug must be administered at the right time point during development," he said..
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)...
on critical illness, 4.6 per cent of claims were declined due to the definition not being met and 2.3 per cent were due to misrepresentation..
(soundbite of les pommes de ma douche's "trompettes de la renommee") transcript provided by npr, copyright npr..